COMMUNIQUÉS West-GlobeNewswire

Oxford Immunotec Announces Preliminary Revenue for Fourth Quarter and Full Year 2017

08/01/2018 - 14:30

OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced that based on preliminary [...]

Canada House Wellness Group Annual General Meeting Will be Held at 10 AM on 11th January 2018 in Pickering, Ontario

08/01/2018 - 14:28

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) wishes to [...]

Biomerica Signs Agreements with Beth Israel Deaconess & University of Michigan to Initiate Clinical Study for First of a Kind, Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy (DGT)

08/01/2018 - 14:19

- DGT Designed to identify patient specific foods, that when removed, may alleviate an individual's IBS symptoms - DGT can be used alongside current IBS drug treatments to potentially improve outcomes - Market research [...]

Allscripts to acquire Practice Fusion business

08/01/2018 - 14:01

CHICAGO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ), a global leader in healthcare technology, today announced a definitive agreement to acquire Practice Fusion, for $100 million in cash, subject to [...]

ZIVO Bioscience Subsidiary Wellmetris Selected to Present at Biotech Showcase During JPMorgan Healthcare Conference Jan 7-10 in San Francisco, CA

08/01/2018 - 14:00

KEEGO HARBOR, Mich., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO), a biotech/agtech R&D company, announced today that its WellMetris subsidiary will be presenting at the Biotech Showcase at [...]

Adaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy Company

08/01/2018 - 14:00

PHILADELPHIA and OXFORD, United Kingdom, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, today announced that it has successfully manufactured [...]

Teneobio Announces a Strategic Alliance with TESARO to Develop the Next Generation of Immuno-Oncology, Multispecific Antibodies

08/01/2018 - 14:00

MENLO PARK, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Teneobio, Inc., a next generation multi-specific antibody therapeutics company announced today the initiation of a research collaboration and licensing agreement [...]

AMAG Pharmaceuticals Announces Preliminary 2017 Financial Results and Provides 2018 Guidance

08/01/2018 - 14:00

WALTHAM, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today provided a business update, including preliminary unaudited fourth quarter and full year 2017 financial results and 2018 [...]

Athenex Announces Chinese FDA Allowance of Investigational New Drug Application of Oraxol to Begin Clinical Trials

08/01/2018 - 14:00

BUFFALO, N.Y., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the Development and Commercialization of Treatments for Spinal Muscular Atrophy

08/01/2018 - 14:00

AveXis acquires exclusive rights to entire NAV Technology Platform for the development of treatments for SMA Amended agreement permits assignment by AveXis upon a change of control without REGENXBIO’s consent REGENXBIO [...]

Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue

08/01/2018 - 14:00

Board Member Keith Sullivan Appointed Interim General Manager of miraDry Miramar Labs Officially Named miraDry, a Sientra Subsidiary Universal Shelf Registration Filed on Form S-3 SANTA BARBARA, Calif., Jan. 08, 2018 ( [...]

Ascendis Pharma Provides Update on Rare Disease Endocrinology Pipeline and Presents Initial Phase 1 Data for TransCon PTH

08/01/2018 - 14:00

COPENHAGEN, Denmark, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare [...]

UroGen Pharma Appoints Former Kite Pharma Executive Christine Cassiano as Corporate Affairs Officer

08/01/2018 - 14:00

Kate Bechtold, Also Formerly of Kite Pharma, to Join the Expanded Communications Team as Director of Corporate Communications & Investor Relations RA’ANANA, Israel, and NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) -- [...]

SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2017

08/01/2018 - 14:00

CARLSBAD, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]

BIOSIG TECHNOLOGIES COMPLETES PRIVATE PLACEMENT

08/01/2018 - 14:00

Santa Monica, CA, Jan. 08, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

Inovio Receives Milestone Payment from MedImmune as MEDI0457 and Checkpoint Inhibitor Combination Trial in Head and Neck Squamous Cell Cancer Advances to Phase 2

08/01/2018 - 14:00

PLYMOUTH MEETING, Pa., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) announced today it has received a milestone payment from MedImmune as MEDI0457 (formerly called INO-3112 which [...]

XOMA Strengthens Leadership Team with Appointments of Chief Business Officer and General Counsel

08/01/2018 - 13:00

EMERYVILLE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA ), a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced the appointments of Dee Datta, Ph. [...]

IRIDEX Announces Preliminary Operational and Financial Results for 2017 Fourth Quarter and Full Year

08/01/2018 - 13:00

MOUNTAIN VIEW, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX ) today provided preliminary operational and financial results for the fourth quarter and full year ended December 30, 2017. [...]

Kamada Announces Interim Results from Phase 2 Clinical Trial of Intravenous Alpha-1 Antitrypsin Treatment for Prevention of Lung Transplant Rejection

08/01/2018 - 13:00

Kamada’s IV AAT Demonstrated Favorable Safety and Tolerability Profile in 10 Patients During First Six Months of Treatment, Consistent with Previously Observed Results in Other Indications Next Interim Report Expected [...]